Hanmi’s IMD pidogul approved in Italy

Published: 2012-01-10 06:56:00

Updated: 2012-01-10 06:56:00

Hanmi Pharmaceutical announced Monday that the firm received an approvable letter for Pidogul (clopidogrel napadisilate monohydrate) tablets, one of its incrementally modified drugs (IMDs), from Italian health authorities, following the first approval from Britain’s health watchdog the Medicines and Healthcare Products Regulatory Agency (MHRA) on Nov. 25, 2010.

The approval by the Italian re...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.